Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2, published by HL7 Clinical Decision Support Workgroup. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-sulindac | Version: 1.0.0-ballot | |||
Draft as of 2018-07-02 | Computable Name: Valueset_sulindac | |||
Copyright/Legal: (copyright expectations unknown) |
ValueSet containing drug identifiers for sulindac.
References
http://www.nlm.nih.gov/research/umls/rxnorm
Code | Display |
10237 | Sulindac |
198238 | Sulindac 150 MG Oral Tablet |
198239 | Sulindac 200 MG Oral Tablet |
199279 | Sulindac 100 MG Oral Tablet |
316755 | Sulindac 150 MG |
316756 | Sulindac 200 MG |
333359 | Sulindac 100 MG |
374003 | Sulindac Oral Tablet |
1163018 | Sulindac Oral Product |
1163019 | Sulindac Pill |
Expansion based on codesystem RxNorm version ??rx1
This value set contains 10 concepts.
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |